The use, tapering, or stopping of which medications can be associated with GPP?

Featuring Brad Glick, DO, MPH | AAD Board of DirectorsProgram Director, Dermatology Residency, Larkin Health System, Palm Springs CampusAssistant Clinical Professor of Dermatology, Herbert Wertheim College of MedicineMiami, Florida | Published September 01, 2023